Changes in HDL Cholesterol and Cardiovascular Outcomes After Lipid Modification Therapy

Study Questions:

Are increases in high-density lipoprotein cholesterol (HDL-C) after starting lipid-modifying therapy (LMT) associated with a reduction in cardiovascular outcomes, independent of changes in low-density lipoprotein cholesterol (LDL-C)?